Search
Now showing items 1-10 of 14
Preprint
Should COVID-19 be branded to Viral Thrombotic Fever?
| Date Issued:
2021 | Copyright:
open access
Preprint
Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum (preprint)
| Date Issued:
2021 | Copyright:
open access
Preprint
Three SARS-CoV-2 reinfection cases by the new Variant of Concern (VOC) P.1/501Y.V3
| Date Issued:
2021 | Copyright:
open access
Preprint
COVID-19 epidemic in the Brazilian state of Amazonas was driven by long-term persistence of endemic SARS-CoV-2 lineages and the recent emergence of the new variant of concern P.1.
| Date Issued:
2021 | Copyright:
open access
Preprint
Unlike Chloroquine, mefloquine inhibits SARS-CoV-2 infection in physiologically relevant cells and does not induce viral variants
| Date Issued:
2021 | Copyright:
open access
Preprint
Multiple Introduction of SARS-CoV-2 C.37 Lambda Lineage in the Southern Brazilian Region
| Date Issued:
2021 | Copyright:
open access
Preprint
Effectiveness of Face Masks in Blocking the Transmission of SARS-CoV-2: a Preliminary Evaluation of Masks Used by SARS-CoV-2-Infected Individuals
| Date Issued:
2021 | Copyright:
open access
Preprint
A potential SARS-CoV-2 variant of interest (VOI) harboring mutation E484K in the Spike protein was identified within lineage B.1.1.33 circulating in Brazil (preprint)
| Date Issued:
2021 | Copyright:
open access
Preprint
Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine and Pyronaridine: In vitro Activity Against SARS-CoV-2 and Potential Mechanisms - Short running title: Ebola SARS-CoV-2 inhibitors
| Date Issued:
2021 | Copyright:
open access
Preprint
Non-permissive SARS-CoV-2 infection in human neurospheres (preprint)
| Date Issued:
2021 | Copyright:
open access